Results 101 to 108 of about 4,503 (108)

Differences in the Serum 4β-hydroxycholesterol Levels of Patients with Chronic Hepatitis C Virus (HCV) Infection: A Possible Impact on the Efficacy and Safety of Interferon (IFN)-free Treatment. [PDF]

Intern Med, 2018
Hirayama T, Ikegami T, Honda A, Miyazaki T, Yara SI, Kohjima M, Nakamuta M, Matsuzaki Y.   +7 more
europepmc   +1 more source

Validation of 4β-hydroxycholesterol and evaluation of other endogenous biomarkers for the assessment of CYP3A activity in healthy subjects. [PDF]

Br J Clin Pharmacol, 2014
Kasichayanula S, Boulton DW, Luo WL, Rodrigues AD, Yang Z, Goodenough A, Lee M, Jemal M, LaCreta F.   +8 more
europepmc   +1 more source

Untargeted Metabolomics Reveal New Endogenous Plasma Biomarkers Associated with CYP3A Inhibition in Humans. [PDF]

Clin Pharmacol Ther
Yee SW, Kadar EP, Cerny MA, Vourvahis M, Tang LWT, Obach RS, Troutman MD, Varma MVS.   +7 more
europepmc   +1 more source

A comparison of 4β-hydroxycholesterol : cholesterol and 6β-hydroxycortisol : cortisol as markers of CYP3A4 induction. [PDF]

Br J Clin Pharmacol, 2013
Mårde Arrhén Y, Nylén H, Lövgren-Sandblom A, Kanebratt KP, Wide K, Diczfalusy U.   +5 more
europepmc   +1 more source

Evaluation of 4β-Hydroxycholesterol as a Clinical Biomarker of CYP3A4 Drug Interactions Using a Bayesian Mechanism-Based Pharmacometric Model. [PDF]

CPT Pharmacometrics Syst Pharmacol, 2014
Leil TA, Kasichayanula S, Boulton DW, LaCreta F.   +3 more
europepmc   +1 more source

4β-Hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans. [PDF]

Br J Clin Pharmacol, 2011
Diczfalusy U, Nylén H, Elander P, Bertilsson L.   +3 more
europepmc   +1 more source

27-Hydroxycholesterol in bile duct tissue promotes cholangiocarcinoma progression through estrogen receptor signaling. [PDF]

Am J Cancer Res
Konishi N, Miyazaki T, Shimoda M, Morishita Y, Honda A, Ikegami T, Suzuki S.   +6 more
europepmc   +1 more source

The Disruption of <i>Cyp7b1</i> Controls IGFBP2 and Prediabetes Exerted Through Different Hydroxycholesterol Metabolites. [PDF]

Int J Mol Sci
Martínez-Beamonte R, Guillén N, Sánchez-Marco J, Herrera-Marcos LV, Surra JC, Navarro MA, Barranquero C, Arnal C, Puente JJ, Rodríguez-Yoldi MJ, Mendiara I, Domeño C, Nerín C, Geurts AM, Osada J, Laclaustra M.   +15 more
europepmc   +1 more source